Bristol-Pfizer anticlot drug gets key EU approval
European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.
Nov 20, 2012
0
0
European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.
Nov 20, 2012
0
0
First developed in the 1950s, beta blockers have been a mainstay in medicine for decades, used to treat everything from heart disease to stage fright to glaucoma. But some older classes of beta blockers are causing new concerns.
Nov 12, 2012
1
1
(HealthDay)—A hoped-for effect of fish oil supplements in preventing an irregular heartbeat that often follows heart surgery did not materialize in a major new trial.
Nov 5, 2012
0
0
A new anticoagulant called apixaban is superior to warfarin in preventing stroke with consistent effects across a wide range of stroke and bleeding risk in patients with atrial fibrillation, according to Duke University Medical ...
Oct 1, 2012
0
0
Medical residents training to work in the emergency department need more formal stroke training, says a study presented today at the Canadian Stroke Congress, noting that, as the first point of contact in stroke care, they ...
Oct 1, 2012
0
0
(AP)—Advisers to European Union regulators have recommended approval of a new anti-clotting drug for use by adults with a common irregular heart rhythm that boosts risk of strokes or blood clots, drugmakers Bristol-Myers ...
Sep 21, 2012
0
0
(Medical Xpress)—Findings from a recent American Heart Association/American Stroke Association survey noted the increased awareness in patients suffering from atrial fibrillation and the correlation between this condition ...
Sep 6, 2012
0
0
(HealthDay) -- When common heart drugs such as digitalis and digoxin are combined with some chemotherapy drugs, the effect appears to be an increase in the death of cancer cells, according to French researchers.
Jul 18, 2012
0
0
Fewer people died or needed expensive long-term care when their physicians focused on the top risk factors for stroke and dementia, according to research reported in the Journal of the American Heart Association (JAHA).
Jul 17, 2012
0
0
(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.
May 21, 2012
0
0